Registry for people with antithrombin deficiency
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This registry gathers information from people who have an antithrombin deficiency, a blood clot–related condition. It aims to better understand the condition, including cases where the exact genetic cause is not yet identified, which can help future care and research.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed antithrombin deficiency by genetic testing, or by symptoms/lab results even if the specific gene cause isn’t identified yet
- Your blood test and/or clinical findings suggest antithrombin deficiency (not just a suspicion)
- If your genetic cause is unknown, the study must still consider your condition as “phenotypic” (based on how it shows up in you)
- You (or your medical team) can share the information needed for a research registry
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks back at patient records to see how antithrombin (a medicine that helps prevent blood clots) was used in intensive care or during surgery. It does not test a new treatment, but helps doctors understand if the medicine was given appropriately.
This is a “registry” study that collects information about people who have a confirmed blood clot in a vein, lung, or a superficial vein. It may help doctors understand outcomes over time, especially what happens in the first few months after diagnosis.
This study keeps an international registry of people with antiphospholipid syndrome (APS) who are taking direct oral blood thinners. It may help doctors better understand how APS patients do over time and improve future care, even if you’re not asked to change treatment.
This study keeps a registry to follow people with antiphospholipid syndrome (APS) who have had arterial blood clots (like stroke). It collects information about the treatment approach your clinician chooses to see how different antithrombotic regimens may perform and be tolerated.
This registry collects information from people who have a blood clot in a leg or a clot in the lung. It helps researchers understand how these conditions are treated in real life.
This study collects health information from people who have alpha-1 antitrypsin deficiency. It may help doctors better understand the condition and improve care over time.
Hear when a new Antithrombin III Deficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.